Natixis Advisors’s Privia Health PRVA Stock Holding History

Natixis Advisors’s Portfolio PRVA Stock Details PRVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$416K	Buy	16,196 +2,361	+17%	+$54.7K	﹤0.01%	1730
2026 Q1	$285K	Sell	13,835 -6,517	-32%	-$147K	﹤0.01%	1649
2025 Q4	$483K	Buy	20,352 +1,221	+6%	+$29.7K	﹤0.01%	1455
2025 Q3	$476K	Sell	19,131 -796	-4%	-$17.1K	﹤0.01%	1503
2025 Q2	$458K	Buy	19,927 +2,176	+12%	+$50.4K	﹤0.01%	1484
2025 Q1	$399K	Buy	17,751 +2,342	+15%	+$54.4K	﹤0.01%	1505
2024 Q4	$301K	Buy	15,409 +2,360	+18%	+$46.8K	﹤0.01%	1556
2024 Q3	$238K	Sell	13,049 -7,008	-35%	-$134K	﹤0.01%	1550
2024 Q2	$349K	Buy	+20,057	New	+$355K	﹤0.01%	1495
2023 Q3	–	Sell	-12,480	Closed	-$326K	–	1520
2023 Q2	$326K	Buy	+12,480	New	+$330K	﹤0.01%	1424

Other funds holding PRVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Natixis Advisors's PRVA Position: Q2 2026 in Review

Natixis Advisors increased its Privia Health (PRVA) stake by 17% in Q2 2026, buying an estimated $54.7K and bringing the position to 16,196 shares worth $416K. The position accounts for ﹤0.01% of the portfolio, ranked #1730.

Natixis Advisors first reported a position in PRVA in Q2 2023 and has held it in 10 quarters since. The position peaked at $483K in Q4 2025. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

Natixis Advisors held 16,196 shares of Privia Health worth $416K as of Q2 2026.
Natixis Advisors bought 2,361 Privia Health shares in Q2 2026, an estimated $54.7K.
Privia Health made up ﹤0.01% of Natixis Advisors's portfolio in Q2 2026, its #1730 holding.
Natixis Advisors first reported a position in Privia Health in Q2 2023 and has held it in 10 quarters since.
Natixis Advisors's Privia Health position peaked at $483K in Q4 2025.
301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Natixis Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.